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Theassessmentofcoronaryarterycalcium(CAC)by
ECG-gated non-contrast enhanced computed tomogra-
phy(NCCT)hasachievedwidespreadclinicalacceptance
as a measure of coronary atherosclerosis and future car-
diacrisk.ACACscoreof0isassociatedwithanexcellent
prognosis
1,2 while elevated levels provide incremental
prognostic information above and beyond that of con-
ventional cardiovascular risk factors in both Caucasian
3-5
andmultiethnicpopulations.
6Speciﬁcally,theCACscore
has been consistently shown to be more predictive of
cardiac outcomes as well as all-cause mortality than the
Framingham risk score.
7,8 Guidelines have been
increasinglyfavorableregardingtheuseofCACscanning
and currently the test is commonly used in asymptomatic
patients for predicting future coronary events and in
guiding the intensity of preventive therapies.
In this issue of JNC, Gupta et al report a novel
application of gated NCCT obtained with the same study
used for CAC assessment. They demonstrate a rela-
tionship between areas of hypo-attenuation on NCCT
and irreversible defects on SPECT myocardial perfusion
imaging. Using a cut-off of value of 27.2 HU, they
report a sensitivity and speciﬁcity of 97.4% and 98.7%
for the detection of non-reversible perfusion defects
on post-stress and rest imaging with technetium-99m
sestamibi.
Assessing the presence of prior myocardial infarc-
tion (MI) by NCCT could add signiﬁcantly to the
clinical value of NCCT. While the CAC score is
strongly predictive of patient outcome, it is not highly
predictive of coronary stenosis.
9 Knowing that a patient
with coronary calciﬁcation had prior MI could help in
the prediction of signiﬁcant coronary artery disease
from the NCCT. Further, since NCCT is increasingly
performed as part of SPECT or PET–MPI studies,
knowledge of prior MI could add to the information
provided by the combined scans.
There are, however, several issues with the report
by Gupta et al that suggest that the observations should
be taken as preliminary. For example, they used stan-
dard rest sestamibi scanning to deﬁne non-reversibility
of perfusion defects, and throughout the manuscript
refer to the non-reversible defects as chronic MI. As
mentioned by the authors, it is well known that hiber-
nating myocardium could show non-reversible defects in
patients without prior MI,
10,11 and that the prediction of
prior MI is enhanced by the use of nitroglycerin prior to
the rest injection with sestamibi imaging. Given this
limitation, it would have been preferable for them to
use the term ‘‘non-reversible defect’’ rather than MI
throughout the manuscript. Further, as pointed out by the
authors, a primary limitation of their study was that on
standard rest sestamibi was used as the reference stan-
dard for non-reversible perfusion defects. It would be
expected that hibernating regions would have been
incorrectly classiﬁed as infarct by their approach. In
addition, ‘‘visual assessment of perfusion abnormalities
by the referring physicians’’ was used to deﬁne the
presence and location of the non-reversible defects.
Given the known high variability of visual assessment
of SPECT–MPI by experts,
12,13 signiﬁcant inaccuracy
among the various readers in the detection and location
of the perfusion defects must have been present, such
that repeat expert visual reading or quantitative analysis
of the data would have been preferred.
Thus, while this provisional data are interesting and
demonstrate an additional potential use of NCCT, fur-
ther validation is required. It would be important to
examine the ﬁndings with more speciﬁc infarct imaging
modalities such as cardiac magnetic resonance imaging
(CMR), FDG-PET, or possibly nitroglycerin-augmented
Tc-99m agent SPECT
14 or Tl-201 rest-redistribution
SPECT prior to clinical use.
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21If validated in additional studies, information
regarding MI using NCCT would likely be of clinical use
in patients undergoing stress imaging studies. In patients
undergoing PET/CT or SPECT/CT, gated NCCT is fre-
quently performed. The ﬁnding of hypo-attenuation on
NCCT could provide complementary information to the
perfusion study, aiding in distinguishing MI from atten-
uation artifact. Further, hypo-attenuation on NCCT,
along with the coronary calcium score, may add pre-
dictive value in estimating the likelihood of coronary
disease and, thus, improve the overall accuracy of per-
fusion imaging. Finally, as noted above, the information
regarding prior MI could aid in predicting signiﬁcant
CAD in patients undergoing CAC scanning alone.
There has recently been renewed interest in the
additional anatomic measurements, aside from the coro-
nary arteries, that can be obtained from NCCT in order to
best predict the likelihood of developing cardiac disease.
Nasir et al
15 demonstrated that, by applying a validated
algorithm,
16 measurements of left ventricular volume on
NCCT correlated with end-diastolic volume obtained by
CMR. Lin et al
17 reported a relationship between aortic
root dimensions on NCCT and comparative measure-
ments from transthoracic echocardiography and Wolak
et al
18 have established normal ranges of thoracic aortic
measurements for age, gender, and body surface area.
Another application of NCCT that is gaining
momentum is the measurement of epicardial fat volume
(EFV). Epicardial and thoracic fat are routinely imaged
on NCCT and there is now emerging evidence that EFV
is an important parameter in cardiovascular risk strati-
ﬁcation and appears to provide incremental prognostic
information regarding future cardiac events over that
provided by CAC scanning alone.
19,20 In contrast to
coronary calcium that provides a snapshot of the his-
torical lifetime build up of atherosclerotic plaque, EFV
may represent the current state of atherogenesis activity
within the coronary arteries.
8 Recent data also suggest
an intriguing relationship between EFV and myocardial
ischemia.
21,22 Although the mechanism of the relation-
ship of coronary atherosclerosis and epicardial fat
remains unclear, initial studies indicate that peri-coro-
nary epicardial fat is associated with atherosclerosis in
the coronary arteries.
23
The study of Gupta et al provides further evidence
thatthegatedNCCTscanshouldnotsimplybeconsidered
a coronary calcium scan. As additional substantiating
studies emerge, it is plausible that measurements such as
LVsize, thoracic aortic measurements, epicardialfat,and
possibly assessment of prior MI may well become a rou-
tine part of the NCCT. The radiation dose associated with
NCCT is falling
24-26 and the additional clinical imaging
parameters that can be extracted from this data are
increasing.Thechapter oncoronarycalciummay soonbe
considered written, but the pages on NCCT keep turning.
The story is far from complete.
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